Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

2012 ◽  
Vol 48 (8) ◽  
pp. 930-941 ◽  
Author(s):  
Tetsuya Hosaka ◽  
Fumitaka Suzuki ◽  
Masahiro Kobayashi ◽  
Yuya Seko ◽  
Yusuke Kawamura ◽  
...  
2006 ◽  
Vol 119 (1) ◽  
pp. 71.e9-71.e16 ◽  
Author(s):  
Yasuji Arase ◽  
Kenji Ikeda ◽  
Fumitaka Suzuki ◽  
Yoshiyuki Suzuki ◽  
Satoshi Saitoh ◽  
...  

2017 ◽  
Vol 38 (4) ◽  
pp. 627-635 ◽  
Author(s):  
Wei-Fan Hsu ◽  
Chuen-Fei Chen ◽  
Hsueh-Chou Lai ◽  
Wen-Pang Su ◽  
Chia-Hsin Lin ◽  
...  

2020 ◽  
Vol 73 ◽  
pp. S265-S266
Author(s):  
Yan Yue James Fung ◽  
Albert CY Chan ◽  
Tiffany Wong ◽  
Wing-chiu Dai ◽  
Sui-ling Sin ◽  
...  

Hepatology ◽  
2010 ◽  
Vol 52 (4) ◽  
pp. 1232-1241 ◽  
Author(s):  
Henry Lik-Yuen Chan ◽  
Vincent Wai-Sun Wong ◽  
Grace Lai-Hung Wong ◽  
Chi-Hang Tse ◽  
Hoi-Yun Chan ◽  
...  

2019 ◽  
Vol 70 (1) ◽  
pp. e477
Author(s):  
Kenichi Morikawa ◽  
Machiko Umemura ◽  
Koji Ogawa ◽  
Taku Shigesawa ◽  
Kazuharu Suzuki ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
pp. 82-83

ABSTRACT Hepatitis B surface antigen (HBsAg) seems to have significant clinical implications to assess the prognosis of chronic hepatitis B (CHB). We assessed HBsAg levels serially in patients with CHB in a single center in Turkey. How to cite this article: Ozkan H. HBV Treatment in Turkey: The Value of Hepatitis B Surface Antigen Quantification of Chronic Hepatitis B Patients in the Long-term Follow-up—A Single-center Study. Euroasian J Hepato-Gastroenterol 2017;7(1):82-83.


Sign in / Sign up

Export Citation Format

Share Document